CULLEN/FROST BANKERS, INC. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.

Quarter-by-quarter ownership
CULLEN/FROST BANKERS, INC. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$34,356
-37.7%
300
-25.0%
0.00%0.0%
Q1 2023$55,132
+6.4%
4000.0%0.00%0.0%
Q4 2022$51,832
+17.8%
4000.0%0.00%0.0%
Q3 2022$44,000
+4300.0%
400
+7900.0%
0.00%
Q3 2020$1,00050.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders